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HYPERPLASTIC alveolar nodules have been shown to represent the preneo-
plastic state in mouse mammary tumour development (Bern and Nandi, 1961).
With little or no mammary gland substrate (due to the inherited hormonal
pattern), neither nodules nor tumours arise unless an appropriate level of activity
is artificially induced in the tissue.
LAF1 mice (generally considered to be free of the mammary tumour agent),
had previously been shown to be refractory to methylcholanthrene mammary
carcinogenesis (Haran-Ghera, 1961). This failure could, however, be overcome by
stimulating the mammary glands with increased prolactin secretion which in-
duced hyperplastic nodules in this tissue. Simultaneous action ofthe carcinogen
and mammary gland stimulation were foumd to induce preneoplastic lesions that
eventually developed in intact LAF1 mice into autonomous mammary tumours
(Haran-Ghera, 1963).
The present experiments were set up on the basis of these findings, in order
to determine the hormonal requirements for further neoplastic transformation
of the preneoplastic lesions.
The questions raised were thefollowing: (a) whether mammary glandstimula-
tion was only needed during the period of methylcholanthrene application or
throughout the process? (b) whether further development of the induced pre-
neoplastic lesions towards malignancy was dependent on the presence of ovarian
and/or adrenal hormones in the host mice? and (c) if such a dependency on hor-
mones did exist, whether a second exogenous hormonal stimulation would en-
hance the further development ofthe preneoplastic induced lesions?
LAF1 virgin female mice used in the previous experiments were found to have
a low degree of mammary gland substrate. It seemed desirable, therefore, to
carry out the present experiments in two strains ofmice having a different degree
of mammary gland activity. DBA/2 mice (also considered to be free of the
mammary tumour agent), which showed a more stimulated mammary gland
tissue, were chosen as the second strain for the present studies.
MATERIALS AND METHODS
Female mice of the LAF1-(C57L x A/He) F1 and DBA/2 strains, inbred in
our laboratory, were used in these experiments when about 6-8 weeks old. The
mice were housed in an air-conditioned room at 21-23° C., and fed on Purina
Laboratory Chow and water ad libitum. All mice were checked for palpable
tumours once a month, killed when a tumour was observed, or kept until natural
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Maammary gland stimulation was induced by transplantation of a single iso-
logous pituitary, taken from male or female donors 2-3 months old, beneath the
left kidney capsule. This was based on the established evidence by Desclin (1950)
and Everett (1954) that suclh a pituitary. when disconnected from the lhypothala-
mits and transplanted to another site in the body, continues to secrete mainlv
prolactini, eliciting both a mammotropic effect, expressed by marked mammarv
gland stimulation, and a luteotropic effect, as manifested by a continuous dioestrus
cycle. W"hen the hormonal stimulation was intended to act for a limited period,
the transplainted pituitary was removed by excising the whole left kidney.
MIethylcholanthrene was administered as a 0.250/0 solution in acetone, applied
6 times to the skin at fortnightly intervals (each painting applied to a different
area of skin). the treatment starting 10 days after the pituitary implantation, for
12 wI-eeks. Ten days after the last methylcholanthrene application the pituitary
isograft was removed, or allowed to remain in situ for varying periods in other
cases.
The bilaterally adrenalectomized mice were maintained oln 0)5 per cent sodium
chloride in their drinking water ad libitum, and subsequently given intramuscular
injections of 1 mg. percorteii (deoxycorticosterone trimethylacetate) every 4
w%veeks.
Functional mammotropic pituitary tumours (MtT), originally obtained from
lr. J. Furth and maintained by us, were used as a source ofprolactin in ovariecto-
mized mice. MtT was grafted subcutaneously in the back ofthe host and partially
resected at sllitab)le intervals to prevent it from killing the host.
RESULTS
Ma1amnmary tumour induction in LAF1 and DBA 2 mnice
The development of mammary tumours in LAF1 and )BA 2' mice is sum-
marized in Table I.
TABLE I.L-Mammnary' Tumour Induction in LAF1 and DBA 2 Miice
LAF, mnice DBA/2 iicie
- . .5- -
Average Average
Mice bearing latent Mlice bearing latenit
tumours/ 1T'er cenit lerio(l tuniours/ Per cenit period
Treatment survivors* tumiourIs (days) sri'Vivors tuirmours (days)
Controls 0/80 - 3/86 3 3 638
-CI( x 6 1/435 2 37a 40/108 37 256
Pituitary graft . 3 '60 3 52(0 41'43 9 530
(15 weeks)
Pituitary graft 35/74 47 350 39/350 78 210
(13 weeks) +MIC x 6
* Aice that (lie(l before the first tuimour appeared in each group wvere niot ineluded.
AMC = AMethvicholanthrene.
Trhe spontaneouis incidence was O per cent in untreated LAF1 mice and 3.5
pei cent in 1)BA/2 mice. The incidence remained low in LAF1 mice after 6
biweekly methylcholanthrene skin paintings, but rose to 37 per cent in DBA '2
mice after such treatment. Excess of prolactin secretion, produced bv a single
pituitary intrarenal implant for 1t5 weeks. induced marked mammary gland
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stinmulation in all mice, as well as 5 per cent mammary tumours in LAF1 mice
and 9 per cent in DBA/2 mice. A cocarcinogenic action was observed when
induced mammary gland stimulation by intrarenal pituitary isograft acted con-
currently with 6 biweekly methylcholanthrene applications for 3 months; mam-
mary tumours developed in 78 per cent of the treated DBA/2 mice and in 47
per cent of the LAF1 mice. The average latent period for tumour developnment
was shorter in DBA 2 mice-210 days compared to 350 days in LAF1 mice.
In both groups tumours appeared at different initervals (5 to 60 weeks) after the
initiation of the preneoplastic lesions induced by excess of prolactin and methyl-
cholanthrene (Fig. 1).
A comparative study of the oestrus cycle
The different reactivity of the two strains of mice to the carcinogenic action
of methylcholanthrene could indicate a different inherited hormonal pattern in
these strains, by causing different degrees of mammary gland substrate deve-
lopment a critical factor in tumour induction by the carcinogen. Mammary
gland stimulation is induced through the action of oestrogens on the pituitary
mammotropes (Lyons, Li and Johnson, 1958). The different degree of mammlary
gland stimulation in LAF1 and DBA,/2 mice could thus be due to a different rate
ofoestrogen secretion in these strains. This was examined by studying the oestrus
cycle in normal LAF1 and DBA/2 mice, using the vaginal smear evaluation.
In IDBA/2 mice, 15 of 20 mice examined revealed a normal oestrus cvcle
lasting 4-6 days. In LAF1 mice, only 7 of 20 mice examined showed a 4-7 day
oestrus cycle, with a prolongation of dioestrus for 8-10 days in the remaining
animals. The vaginal smears in LAF1 mice carrying an intrarenal isologous
pituitary graft were also recorded. Several days after this implantation, the
oestrus cycle disappeared almost completely, and a continuous dioestrous phase
was recorded for as long as the host carried the pituitary isograft. A normal
oestrus cycle in the host was noted 3-4 days after the isograft was removed.
The role of mammary gland stimulation
LAF1 mice received an intrarenal pituitary implant; 10 days later the miiice
carrying the implant received methylcholanthrene (MC) treatment for 12 Meeks.
The mice were then divided into three groups. In the first group, the implant
was removed from the host 10 days after the last MC apDlication; in the second
group, the implant was left in situ for 6 months, i.e. removed 3 months after the
last MC application; and in the third group, the implant was left in situ through-
out life. Parallel controls of pituitary intrarenal implants for different periods
were also set up.
As seen in Table II, a similar incidence of mammary tumours (57 per cent)
occurred whether mammary gland stimulation was maintained throughout life
as compared with the limited period of the concurrent action with the carcinogen
(46 per cent). Both 6 months and life-long stimulations did not affect the average
latent period of tumour development.
Continuous mammary gland stimulation throughout life without additional
carcinogen treatment induced mamimary tumours in 13.6 per cent of LAF1 mice
carrying the intrarenal pituitary isograft and shortening of the period of extra
mammary gland stimulation reduced this tumour incidence.
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TABLE II.-Maximum Thresholdfor Mammary Gland Stimulation
in Mammary Tumorigenesis in LAF1 Mice
Treatment
Pituitary graft continuously + MC X- 6
Pituitary graft 6 months + MC x 6
Pituitary graft 3 months + MC x 6
Pituitary graft continuously
Pituitary graft 6 months
Pituitary graft 3 months
MC x 6
3IC =Methylcholanthrene.
Mice bearing
tumours/survivors
40/70 57%
. 38/86 44%
34/75 45-6%
6/44 13-6%
4/50 8%
2/60 3%
1/45 2%
Average latent
period (days)
370
345
350
420
435
520
375
The effect of ovariectomy and adrenalectomy on the development of the preneoplastic
lesions
Preneoplastic lesions were induced in LAF1 and DBA/2 mice by the concurrent
action ofmammary gland stimulation by intrarenal pituitary isograft and methyl-
cholanthrene treatment for 3 months. The mice were then divided into three
groups: In group 1, the pituitary implant was removed 10 days after the last
MC application; in group 2, the implant and both ovaries were removed at the
same time; and in group 3, a triple operation was performed involving the re-
moval of the pituitary implant, both ovaries and both adrenals.
TABLE III.-The Effect ofOvariectomy and Adrenalectomy on Further
Growth ofPreneoplastic Nodules in LAF1 and DBA/2 Mice
Treatment
Pituitary graft 15 weeks
+MC x 6
Pituitary graft 15 weeks
+ MC x 6-- ovex + adrex
Pituitary graft 15 weeks
+MC x 6-ovex
DBA/2 mice
Mice bearing
tumours/ Average latent
survivors period (days)
39/50 78% 210
17/30 57%
14/26 54%
LAF1 mice
Mice bearing
tumours/ Average latent
survivors period (dayTs)
35/74 47% 350
226 . 3/51 6%o
210 . 3/47 6%
324
417
Mc - Methylcholanthrene.
Ovex = Ovariectomy.
Adrex Adrenalectomy.
As seen in Table III and Fig. 1, the removal of the ovaries and adrenals or of
the ovaries alone inhibited mammary tumour development in LAF1 mice-a
6 per cent incidence of mammary tumours in castrated mice or double operated
animals, compared to 47 per cent in the intact treated mice. Contrary to LAF1
mice, in DBA/2 mice only a slight decrease in mammary tumour development
was observed-57 per cent in the operated mice, compared to 78 per cent in the
intact mice. Similar effects on the further development of the preneoplastic
induced lesions in LAF1 and DBA/2 mice were obtained whether the mice were
ovariectomized and adxenalectomized or only ovariectomized. The latent period
of tumour development in DBA/2 mice was significantly shorter than in LAF1
mice (Fig. 1). These results indicate that the concurrent treatment of mammary
gland stimulation and carcinogen induce autonomous preneoplastic lesions in
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DBA/2 mice, whereas the preneoplastic lesions in LAF1 mice are dependent on
the function of the ovaries for their further neoplastic transformation.
The persistence of the preneoplkstic lesions
Preneoplastic lesions were induced in LAF1 mice, after which the animals
were ovariectomized. A third of these mice were regrafted 12 weeks later with
one ovary beneath the right kidney capsule. (The functioning ofthe implant was
checked by studying the vaginal smears of these mice. This revealed again the
typical oestrus cycle for this strain, whereas the control ovariectomized mice
showed a continuous dioestrus cycle.) As seen in Table IV, ovariectomy in-
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FIG. 1.-Histogram of mammary tumour incidence. Each square represents a tumour.
Ovex = Ovariectomy.
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hibited mammary tumour development from the induced preneoplastic lesions.
The reimplantation of one ovary affected these initiated preneoplastic dependent
lesions-20 per cent of these mice developed mammary tumours, compared to a
4'6 per cent tumour incidence in ovariectomized hosts carrying such preneoplastic
lesions (Table IV and Fig. 1).
TABLE IV.-Resurnption of Growth of the Preneopiacstic
J)ependent Lesions in LAF1 Mice
AlamIllar.y tulrlnotl
ineidlence
No. tumours/ Average latent
Tr-eatimieiit total Per eent period (days)
Pituitary graft 1 55 weeks 35/74 47 . 3.5)
+ MC x 6
Pituitary graft 15 weeks 2/43 4 6 . 44(0
+ MC x 6 . ovariectomyv
Pituitary graft 15 weeks
- AIC x 6 ovex 7 /35 241 385
I2 weeks
-- ovalr ill)plant
Pituitary graft 15 weeks
+ MC x 6- ovex 0/30
12 w-eeks
MtT graft
MC( -=Methylcholanthremme.
Ovex Ovariectomy.
,I\tt -Lamynotrolpic pituitary tvnnour.
Another group of ovariectomized mice, in wlhich preneoplastic lesions were
induced, was grafted after a 3-month interval with a functioning mammotropic
pituitary tumour secreting prolactin and growth hormone (Furth. Gadsden.
Clifton and Anderson, 1956). This treatment failed to enhance the growth of
the preneoplastic lesions: no mammary tumours developed in this group (Table
IV).
)ISCUSSION
A certain degree of mammary gland stimulation is known to be essential for
mammary tumour development, with oestrogens playing a major role in stimulat-
ing mammary gland proliferation through its influence on the pituitary mammo-
tropes. The primary difference between mouse strains exhibiting a low and
high mammary tumour incidence may lie in the available hormones. especially
oestrogens? capable of causing stimulation and nodule formationi in the mammary
tissue. T'he proliferating mammary gland cells are a more favourable substrate
for methylcholanthrene penetration (Dao. Bock and Crouch, 1959). Comparing
the vaginal smears of LAF, and DBA 2 mice, the more regular oestrus cycle of
1)BA 2 mice would suggest a normal level of oestrogen secretion, stimulating the
mammary glands, which would allow mammary tumours to arise after methyl-
cholanthrene application, whereas the LAF, mice. with the irregular oestrus cycle.
could explain the refractoriness ofthe poorly stimulating mammary tissue (lacking
the nodules) to methylcholanthrene treatment.
In the present experiment, once the preneoplastic transformationi was induced.
the continuation or discontinuation of mammary gland stimulation failed to
1S
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change significantly the tumour incidence or its latency. Mammary gland
stimulation seemed therefore of importance mainly in the initiation of mammarv
tumour induction in mice, rather than in promoting tumour development. Con-
tinuous mammary gland stimulation by subcutaneous isografts of hypophyses
has been showni to lead to mammary tumour development (Loeb and Kirtz,
1939: Miihlbock and Boot, 1959). In the present experiments similar obser-
vationis were obtained in mice carrying the intrarenal hypophvsis implant through-
out life or for a limited period of 6 months.
I'he induced preneoplastic lesions were found to be autonomous lesions in
IDBA 2 mice, progressing to malignant autonomous tumours in ovariectomized
aind adreinalectomized mice. but dependeiit on ovarian hormones for further
developmeint to autonomous mammary tumours in LAF1 mice. The shorter
latenit period of mammary tumour development in DBA,,2 mice also indicated
the more favourable " inherited " hormonal influence (Bittner, 1942) in this
strain. in which the preneoplastic transformatioii towards autonomy is com-
pleted witlhin thLe 3 months of the concurrent treatment of mammary gland
stimulation and methylcholanthrene application. Consequently. less time is
required for full palpable tumour development in this case.
Similar results on the further development of the preneoplastic lesionls in
LAF1 anid DBA 2' mice were obtained when mice were ovariectomized and ad-
renalectomized or only ovariectomized, suggesting that the ovarian hormones
are the main contributors to the autonomous neoplastic transformation: DBA 2
mice with a probable higher level of oestrogen secretion (reflected in the regular
oestrus cycle) could enhance the neoplastic autonomous transformation of the
preneoplastic lesions before the removal of the ovaries, whereas LAF1 mice, with
lower oestrogen levels (expressed by the irregular oestrus cycle) needed additional
ovarian stimulation to complete this neoplastic autonomous transformation.
While the preneoplastic lesions induced in LAF1 mice did not proceed to
malignancy in the absence of the ovaries. regrafting of one ovary 3 months later,
encouraged the persistence of the preneoplastic changes in the tissue, permitting
some of them to proceed to palpable tumour growths. Andervont and Dunii
(1964) have shown that preneoplastic changes, induced by diethylstilboestrol,
could be further stimulated to neoplastic transformation after a longer interval
of removal of the hormonal promoting factor than in our present experiment:
A second exogenous hormone treatment after a 26-week interval was still effective
in promoting the latent preneoplastic lesions. The induced preneoplastic lesions
are, in certain strains, dependent lesions, requiring further hormonal stimulation
to produce the autonomous variant. They can, in otlher words, remain in a
dormant" state whetn this additional hormonal stimulationis interrupted, and
caII be reactivated when additional hormonal stimulation is provided.
Furth and Kim (1961) have shown that in rats, a manumotropic pituitary
tumour (MtT), secreting prolactin and growth hormone, when grafted into rats
whose primary mammary tumour had regressed as a consequence of ovariectomy
or hypophysectomy, caused resumption of progressive tumour growth. Im-
plantation of MtT was therefore used in our experiment, as a parallel to the
ovarian graft, in trying to enhance the development of dependent preneoplastic
lesions towards autonomy. But MtT. unlike ovarian graft, proved ineffective
in causing this transformation. These results might point to the possibility that
ovarian oestrogens contribute to the development of mammary tumnours. not
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only as stimulants to mammotrope secretion, but also as a direct effect oni the
autonomous neoplastic transformation in mice. However. more evidence for
this concept is required.
StMMARY
rFlhe induction of preneoplastic mammary nodules and their hormonal re-
(quirements for progression to neoplasia were studied in the LAF1 anld DBA '2
strains of mice, which normally have a 0-3.5 per cent incidence of spontaneous
mammary tumours, and which are considered to be free of the mammary tumour
agent. LAF1 mice were refractory to methylcholanthrene mammary carcino-
genesis, whereas DBA/2 mice were susceptible-reflecting a different degree of
primary mammary gland substrate, associated with their respective inherited
hormonal patterns. This was checked by comparing the oestrus cycles in the
two strains. Concurrent stimulation of mammary gland, through excess of
prolactin secretion brought about by a pituitary intrarenal isograft, and acting in
conjunction with methylcholan-threne applications, was effective in inducing
preneoplastic mammary lesions in both straiiis. The mammary gland stimula-
tion was only needed for the initiation of mammary tumour development, not
for its promotion. The preneoplastic lesions induced in LAF1 mice were found to
depend, for their further neoplastic transformation, on the ovariani hormones;
similar lesions induced in IDBA'2 mice already constituted autoniomous trans-
formations, after the initial inductive treatment, having the capacity ofdeveloping
into palpable tumours in ovariectomized and adrenalectomized hosts. The
growth of the dependent preneoplastic lesions in ovariectomized LAF1 mice
could be restored by regrafting an ovary into these hosts, wNhile failing to
respond to prolactin secretion brought about by a mammotropic pituitarv tumour
grafted subcutanieouslyv.
The author is indebted to Dr. W. E. Poel for his interest and valuable assistanice
in taking (care of some phases of this work while the author was abroad; also to
Dr. I. Berenblum for his encouragement and advice, and to Mr. S. Yecheskel for
his competent technical assistance.
REFERENCES
ANDERVONT, H. B. AND DUNN, T. B. (1964) J. natn. Cancer Inst., 33, 143.
BERN, H. A. and NANDI, S.-(1961) Prog. exp. Tumor Res., 2, 99.
BITTNER, J. J.-(1942) Cancer Res., 2. 710.
DAO, T. L.. BOCK, F. G. AND CROUCH, S.-(1959) Pr-oc. Soc. exp. Biol. Mred.. 102. 635.
DESCLIN, L.-(1950) Annis Endocr.. 11, 656.
EVERETT, J. W.-(1954) Endocrinology, 54, 685.
FURTH, J., GADSDEN, E. L., CLIFTON. K. H. AND ANDERSON, E.-(1956) Canlcer Req.,
16, 600.
FURTH, J. AND Kim. U.-(1961) in 'Biological Foundation of Cancer Control bv Hor-
mones'. New- York (Academic Press), p. 259.
HARAN-GHERA, N. (1961) Cancer Res., 21, 790.-(1963) Acta Uni. int. Cancr.. 19, 765.
LOEB, L. AND KIRTZ. M. M. (1939) Am. J. Cancer, 36, 56.
LyoNs, W. R., Li. C. H. AND JOHNSON, R. E. (1958) Recent Prog. Hform.. Res.. 14. 219.
MPHLBOCK, 0. ANTD BOOT, L. M. (1959) Cancer Res., 19, 402.